FIELD: medicine. SUBSTANCE: method involves administering medication treatment, applying special kinds of diet and other measures for supporting normal relations between nucleases and their inhibitors activities in animal and human blood as it takes place in healthy people not allowing sharp drop of nucleases activity to arise. EFFECT: enhanced effectiveness of method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING PREPARATION HAVING PROPERTIES OF BONE MARROW | 1991 |
|
RU2033793C1 |
| METHOD FOR DIAGNOSING MALIGNANT TUMORS | 1992 |
|
RU2037152C1 |
| METHOD OF REVEALING INITIATION OF MALIGNANT PROCESS IN HUMAN ORGANISM | 1991 |
|
RU2021612C1 |
| MINIMALLY INVASIVE METHOD FOR DIAGNOSTICS OF LUNG CANCER ON BASIS OF CHANGING COPY NUMBER OF MTDNA HV2 LOCUS | 2018 |
|
RU2678227C1 |
| METHOD FOR TREATING ONCOLOGICAL PATIENTS | 2004 |
|
RU2269356C2 |
| METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
| PHOSPHODIESTERASE 4D7 AS MARKER FOR AGGRESSIVE HORMONE-SENSITIVE PROSTATE CANCER | 2010 |
|
RU2575076C2 |
| METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
| METHOD FOR PROPHYLAXIS OF ONCOLOGICAL DISEASES, OR INFECTIONS MORDIBIDIZED BY BACTERIA OR FUNGI AND PROTOZOA, OR ARTERIOSCLEROSIS, OR DIABETES MELLITUS, OR DISEASES MEDIATED BY DELAYED HYPERRESPONSIVENESS REACTION, OR DISEASES MEDIATED BY SOMATIC CELL GENE MUTATIONS (VARIANTS) | 2004 |
|
RU2269359C2 |
| PHOSPHODIESTERASE 9A AS MARKER OF MALIGNANT TUMOR OF PROSTATE GLAND | 2010 |
|
RU2592668C2 |
